an Open-Label, Randomized, Controlled, Crossover Study to assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in adult Smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Goldenson (2021)
Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
hajek (2020)
Characterizing Gas Exchange Physiology in healthy Young Electronic-Cigarette Users with hyperpolarized 129Xe MRI: a Pilot Study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
he (2021)
Effects of Electronic Nicotine Delivery Systems and Cigarettes on Systemic Circulation and Blood-Brain Barrier: Implications for Cognitive Decline.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
heldt (2021)
E-cigarettes, nicotine, the lung and the brain: multi-level cascading pathophysiology.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
herman (2020)
Cigarette smoke and electronic cigarettes differentially activate bronchial epithelial cells.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
herr (2020)
Effects of Device Settings and E-Liquid Characteristics on Mouth-Throat Losses of Nicotine Delivered with Electronic Nicotine Delivery Systems (ENDS).
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
hosseini (2023)
Exposure, Retention, Exhalation, Symptoms, and Environmental accumulation of Chemicals During JUUL Vaping.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
hua (2023)
Part two: an unblinded, parallel, randomized study to assess nicotine pharmacokinetics of four Vuse Solo ENDS flavors in smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Keyser (2023)
Tracing the movement of electronic cigarette flavor chemicals and nicotine from refill fluids to aerosol, lungs, exhale, and the environment.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Khachatoorian (2022)